Remembering Etanercept & the Advent of the Biologic Era
Biologic Spending & Price Trends
Canada & E.U. Approve Upadacitinib for RA
EU Approves Remsima SC, a Biosimilar to Infliximab
FDA Approves Amgen’s Infliximab Biosimilar Treatment
Rituximab-abbs Available in the U.S.; Plus Upadacitinib in Phase 3 Trials for PsA
FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin
Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4
FDA Approves the Biosimilar Hadlima (Adalimumab-bwwd)
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 35
- Next Page »